Informazioni
Dr Prajwol Shrestha is a Medical Oncologist practising at Calvary Mater Newcastle and Lake Macquarie Private Hospitals. He provides care across a range of cancer types, mainly GI, breast, skin and H&N cancers.
His early medical training was undertaken at Liverpool, Gosford and Nepean Hospitals, with completion of Basic Physician Training in 2018. Dr Shrestha completed his specialist training in Medical Oncology at Calvary Mater Newcastle and the Central Coast Cancer Centre. He subsequently undertook a fellowship in early-phase clinical trials at Chris O’Brien Lifehouse in Sydney. Prior to relocating to Newcastle, he also worked in a range of clinical settings across Queensland and South Australia.
Dr Shrestha’s emphasizes on individualised treatment with plan tailored to each patient’s clinical needs and preferences, with the aim of supporting both treatment outcomes and quality of life.
Alongside his clinical work, Dr Shrestha is actively involved in clinical research. He has a particular interest in biomarker-driven clinical trials and has undertaken research into liquid biopsy biomarkers in Centenary Institute, RPA. He is a member of several professional organisations, including the American Society of Clinical Oncology, the European Society of Medical Oncology, and the Medical Oncology Group of Australia. He has authored multiple peer-reviewed publications and has presented his work at national and international conferences.
His early medical training was undertaken at Liverpool, Gosford and Nepean Hospitals, with completion of Basic Physician Training in 2018. Dr Shrestha completed his specialist training in Medical Oncology at Calvary Mater Newcastle and the Central Coast Cancer Centre. He subsequently undertook a fellowship in early-phase clinical trials at Chris O’Brien Lifehouse in Sydney. Prior to relocating to Newcastle, he also worked in a range of clinical settings across Queensland and South Australia.
Dr Shrestha’s emphasizes on individualised treatment with plan tailored to each patient’s clinical needs and preferences, with the aim of supporting both treatment outcomes and quality of life.
Alongside his clinical work, Dr Shrestha is actively involved in clinical research. He has a particular interest in biomarker-driven clinical trials and has undertaken research into liquid biopsy biomarkers in Centenary Institute, RPA. He is a member of several professional organisations, including the American Society of Clinical Oncology, the European Society of Medical Oncology, and the Medical Oncology Group of Australia. He has authored multiple peer-reviewed publications and has presented his work at national and international conferences.
“Evidence-based care tailored to each patient — taking the time to explain options and shared decisions.”
— Dr Prajwol Shrestha
Istruzione e formazione
-
2001–2007 MD · Medicine and Surgery
-
2007–2011 Residency · Oncologia
-
2011–2012 Fellowship · Subspecialty training
Carriera e incarichi
-
2011-09–2012-08 Junior consultant
Licenze e assicurazione
Licenze mediche
AU — Organización Médica Colegial de España (OMC)
Certificazioni di specializzazione
European Board of Oncologia
Assicurazione responsabilità professionale:
AmTrust Europe · 1,000,000 EUR copertura · No claims on file
Procedure eseguite
| Procedura | Codice | Conteggio totale |
|---|---|---|
| GP consultation | 99213 | 2,258 |
| Annual physical exam | 99395 | 668 |
| Vaccination administration | 90471 | 2,340 |
| Minor procedure (skin) | 17110 | 851 |
Servizi e prezzi
| Servizio | Durata | Modalità | Prezzo |
|---|---|---|---|
| New patient consultation (60m) | 60 min | in_clinic|telemed | 180.00 EUR |
| Follow-up consultation (30m) | 30 min | in_clinic|telemed|phone | 90.00 EUR |
| Vaccination administration | 120 min | in_clinic | 630.00 EUR |
| Minor procedure (skin) | 30 min | in_clinic | 720.00 EUR |
Studio, team e in pratica
Video
Ricerca e pubblicazioni
indice h: 17 · i10: 6
-
Outcomes of Oncologia in adults — a multi-centre cohort
DOI: 10.7976/euroclin.2025.0 · PMID: 37197950 · citato da 122
-
European registry analysis of Oncologia outcomes
DOI: 10.1367/euroclin.2024.1 · PMID: 37903200 · citato da 176
-
Outcomes of Oncologia in adults — a multi-centre cohort
DOI: 10.8106/euroclin.2023.2 · PMID: 39871204 · citato da 134
Conferenze su invito
- Practical updates in Oncologia European Annual Congress (Oncologia) · Vienna · 2024 · invited
- Single-centre experience in Oncologia National Society Meeting · Gateshead · 2023 · oral abstract
Premi e affiliazioni
Premi
- 🏆 Top-rated Oncologia — Gateshead · EuroClinics Patient Choice · 2025 · regional
Iscrizioni a società
- WONCA Europe — Family Doctors — Member · Dal 2012
- national college of family doctors — Member · Dal 2012
- European Union of Medical Specialists (UEMS) — Member · Dal 2012
Articoli di questo medico
- Patient education Patient guide to Oncologia
- Awareness When should you see a oncologia?
Per pazienti internazionali
- Coordinatore
- Patient liaison · prajwol.shrestha@euroclinics.example
- Assicurazioni internazionali accettate
- Allianz Worldwide · AXA Global · BUPA Global · Cigna Global
Posizione
1 tagRecensioni dei pazienti
4 recensioni verificate4.83
★★★★⯨
4 recensioni
- Bedside Manner
- 4.9
- Knowledge
- 4.9
- Wait Time
- 4.6
- Staff Friendliness
- 4.9
- Ease Of Appointment
- 4.7
- Value For Money
- 4.8
- Would Recommend Pct
- 96.0
Condividi la tua esperienza — aiuta altri pazienti a trovare il medico giusto. Scrivi una recensione →
Recensioni recenti
-
★★★★★ ✓ Verificato Very thorough first visit — explained every step. Booking was easy and the staff were welcoming.
-
★★★★★ ✓ Verificato Took time to listen and reviewed all my previous results. I would absolutely recommend.
-
★★★★☆ ✓ Verificato Professional and knowledgeable. Wait on the day was a bit long, otherwise excellent.